MedTrace Logo

Drug Use Study With Intuniv® in European Countries

NCT05870605 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2023-08-22

No results posted yet for this study

Summary

This study will evaluate and characterize people who are taking Intuniv, analyze prescribing behaviors of physicians, and determine whether Intuniv was correctly prescribed in Belgium, Denmark, Finland, Germany, Ireland, Netherlands, Norway, Spain, Sweden, and the United Kingdom.

Conditions

  • Attention Deficit Hyperactivity Disorder (ADHD)

Interventions

OTHER

No Intervention

This is an observational study utilizing historical de-identified patient level data; therefore no intervention is given.

Sponsors & Collaborators

  • Shire

    lead INDUSTRY

Principal Investigators

  • Study Director · Shire

Eligibility

Min Age
6 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-11-15
Primary Completion
2022-04-30
Completion
2022-04-30

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05870605 on ClinicalTrials.gov